Applicable clinical trials initiated on or after March 7, 2012, must be in compliance with
the new requirement and include the new statement in all informed consent documents.
For the purposes of this rule only, we consider “initiation” of a clinical trial to be the
clearance or approval of any informed consent documents by an IRB or other ethics
review committee.
